The rising interest in GLP-1 agonists for diabetes has generated a discussion about formats: skin-applied devices versus capsules. Typically, GLP-1 therapies were only available in oral form, but the https://brianhqoi143736.blogacep.com/46576481/glp-1-skin-applications-vs-tablets-what-right-for-individuals